TIMOTHY C. GRIFFIN, M.D.
211 DURAND OAK
SHAVANO PARK, TX, 78230
(C) 616-438-5894
tcamgriff@aol.com
Michigan License # 4301097594 exp. 1/31/2017
Texas License H9337 exp. 5/31/15
EDUCATION
University of Michigan Medical School, Ann Arbor, Michigan, M.D., 06/80-05/84.
Hope College, Holland, Michigan, B.A. in Chemistry, 1980. Magna Cum Laude,
Phi Beta Kappa.
PROFESSIONAL EMPLOYMENT
Professor and Section Chief, Pediatric Hematology/Oncology, Baylor College of
Medicine, Howard A. Britton MD Endowed Chair in Pediatric
Hematology/Oncology – Children’s Hospital of San Antonio, 315 N. San Saba
St., Suite 1135, San Antonio, TX 78209
Pediatric Department Chief, Spectrum Health Medical Group – 444 Michigan St.
NE Grand Rapids, MI 49503 – 9/10 – Present
Pediatrician-in-Chief, Helen DeVos Children’s Hospital – 100 Michigan St. NE
MC 250 Grand Rapids, MI 49503 – 9/10 - Present
Memorial Medical Group - Memorial Hospital, 6th Floor, 615 N. Michigan Street,
South Bend, IN 46601 – 10/06-9/10
Cook Children's Physician Network – 801 Seventh Avenue, Fort Worth, TX
76104 – 7/95-9/06.
Pediatric Hematology/Oncology Associates, P.A. – 801 Seventh Avenue, Fort
Worth, TX 76104 – 7/91-6/95.
Fellow in Pediatric Hematology/Oncology. Children's Medical Center of Dallas,
Southwestern Medical School, 1935 Motor St, Dallas, TX 76235 7/88-6/91.
Chief Pediatric Resident. Children's Memorial Hospital, Northwestern University
Medical School, 2300 Children's Plaza, Chicago Il 60614. 7/87-6/88.
Pediatric House Officer. Children's Memorial Hospital, Northwestern University
Medical School, 2300 Children's Plaza, Chicago, Il 60614. 6/84-6/87.
2
BOARD CERTIFICATION
American Board of Pediatrics, 1989.
Sub-board of The American Board of Pediatric Hematology/Oncology, 1992
Recertified, 1998, 2006
PROFESSIONAL ORGANIZATIONS
American College of Physician Executives
American Society of Pediatric Hematology/Oncology
International Society of Pediatric Oncology (SIOP)
American Academy of Pediatrics
Children’s Oncology Group
PROFESSIONAL ACTIVITIES/COMMITTEE MEMBERSHIP
Board of Trustees, American Society of Pediatric Hematology/Oncology, 20062009
Voting Body Steering Committee, Children’s Oncology Group, 2004-2006
Cancer Prevention Committee, American Society of Clinical Oncology, 20042006
Practice
Committee
(Chairman),
American
Society
of
Pediatric
Hematology/Oncology, 2003- 2006
Nominating Committee, Section on Hematology/Oncology, American Academy of
Pediatrics, 2003 – 2006
Clinical Practice Committee, American Society of Clinical Oncology, 2000-2003
Membership Committee, American Society of Clinical Oncology, 1999-2002
Practice Committee, American Society of Pediatric Hematology/Oncology 19992006
Texgene Newborn Screening Advisory Committee, 1998-2000
Texas Department of Health Hemoglobinopathy Consultant, 1991-2006
Manuscript Reviewer for Pediatrics, Cancer, Pediatric Blood and Cancer
CLINICAL RESEARCH ACTIVITIES
Principal Investigator, Children’s Oncology Group, 2001-2006
Non-Hodgkin’s Lymphoma Steering Committee, Children’s Oncology Group,
2004-2006
Non-Hodgkin’s Lymphoma Committee, Children’s Oncology Group, 2000-
3
Non-Hodgkin’s Lymphoma Transition Committee, Children’s Oncology Group,
1999-2000
Non-Hodgkin’s Lymphoma Committee, Pediatric Oncology Group, 1997-1999
Member, Pediatric Oncology Group, 1991-2000
Primary Study Chair, Children’s Oncology Group Protocol #ANHL0121
Primary Study Chair, Pediatric Oncology Group Protocol #9517
Study Committee Member, Children’s Oncology Group Protocol #ANHL06P1
Study Committee Member, Children’s Oncology Group Protocol #ADVL0013
Study Committee Member, Pediatric Oncology Group Protocol #9917
CURRENT COMMUNITY SERVICE ACTIVITIES
Board of Directors, David D. Hunting Branch, YMCA of Grand Rapids
Volunteer Physician, Sunshine Kids Foundation
MEMORIAL HEALTH SYSTEM ACTIVITIES
Memorial Health System Foundation Board of Directors, 2009-2010
Medical Director, Pediatric Hematology/Oncology 2008-2010
Transfusion Committee 2008-2010
COOK CHILDREN’S HEALTH CARE SYSTEM ACTIVITIES
Board of Directors (Chairman) Cook Children's Physician Network, 2001-2003
Executive Committee (Chairman), Cook Children's Physician Network, 20012003
Executive Committee (Vice Chair), Cook Children's Physician Network, 20002001
Board of Directors, (Vice-Chair), Cook Children's Health Care System, 20022004
Cancer Committee (Chairman), Cook Children's Medical Center, 2001-2006
Medical Director, Department of Hematology/Oncology, 2001-2006
H/O Management Council (Chair), Cook Children's Medical Center, 2001 – 2006
Board of Directors (Vice Chairman) Cook Children's Physician Network, 20002001
Credentials Committee (Vice-Chairman), Cook Children’s Healthcare System,
1999 - 2000
Board of Trustees (Vice-Chairman), Cook Children’s Health Plan, 1998-2000
Managed Care Committee (Chairman), Cook Children’s Health Care System,
1997-2000
Board of Directors, Cook Children’s Physician Network, 1997-2003
Finance Committee, Cook Children’s Physician Network, 1997-2000
Board of Directors, Cook Children’s Health Care System, 1997-2005
Ethics Committee (Chairman), Cook Children’s Medical Center, 1995-1998
Medical Subspecialties Division (Chief), Cook Children’s Medical Center, 1997 –
4
1998
JOURNAL PUBLICATIONS
Winter SS, Jiang Z, Khawaja H, Griffin T, Asselin BL, Larson RS. Identification of
Genomic Classifiers that Distinguish Induction Failure in T- lineage Acute
Lymphoblastic Leukemia. Blood 2007: 110:1429-38.
Griffin TC, Weitzman S, Weinstein H, Chang M, Cairo M, Hutchison R Shiramizu
B, Wiley J, Woods D, Barnich M, Gross TG. A Study of Rituximab and
Ifosfamide, Carboplatin, and Etoposide Chemotherapy in Children With
Recurrent/Refractory B-Cell (CD20+) Non-Hodgkin’s Lymphoma and Mature BCell Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology
Group. Pediatr Blood Cancer, 2009: 52:177-181.
Winter SS, Jiang Z, Khawaja H, Griffin T, Devidas M, Asselin BL, Larson RS.
Identification of Genomic Classifiers that Distinguish Induction Failure in Tlineage Acute Lymphoblastic Leukemia. Blood, 2007: 110;1429-1438.
Jeha S, Gaynon PS, Razzouk BI, Franklin J, Kadota R, Shen V, Luchtman-Jones
L, Rytting M, Bomgaars LR, Rheingold S, Ritchey K, Albano E, Arceci RJ,
Goldman S,
Griffin T, Altman A, Gordon B, Steinherz L, Weitman S, Steinherz P. Phase II
Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute
Lymphoblastic Leukemia. J Clin Oncol, 2006; 24:1917-1923.
Abla O, Sandlund JT, Sung L, Brock P, Corbett R, Kirov I, Griffin TC, Blaser S,
Weitzman. A Case Series of Pediatric Primary Central Nervous System
Lymphoma-Favourable Outcome Without Cranial Irradiation.
Pediatr Blood
Cancer, 2006; 47:880-885.
Griffin TC, Hutter JJ, Johnson KK, Moscow JA. A Survey of Clinical Productivity
and Current Procedural Terminology (CPT) Coding Patterns of Pediatric
Hematologist/Oncologists. Pediatr Blood Cancer, 2004; 43:140-7.
Griffin TC, Shuster JJ, Buchanan GR, Murphy SB, Camitta BM, Amylon MD.
Slow Disappearance of Peripheral Blood Blasts is an Adverse Prognostic Factor
in Childhood T-Cell Acute Lymphoblastic Leukemia: A Pediatric Oncology Group
Study. Leukemia, 2000; 14:792-5.
Hutt PJ, Fairbanks VF, Griffin TC, Thibodeau SN,Green M, Hoyer JD Hb Cook
[beta 132(H10) LysThr]: A New Hemoglobin Variant in a Southeast Asian
5
family. Hemoglobin, 1996; 20:371-6.
Bowman WP, Shuster J, Cook B, Griffin TC, Behm F, Pullen J, Link M, Head D,
Carroll A, Berard C, Murphy S. Improved Survival for Children with B-cell Acute
Lymphoblastic Leukemia and Stage IV Small Non-Cleaved Lymphoma: A
Pediatric Oncology Group Study. J Clin Oncol, 1996; 14: No 4, 1252-1261.
Griffin TC, Bowman WP, Winick NJ, Buchanan GR. Treatment of Advanced
Stage Burkitt's Lymphoma in Childhood: Further Experience with Total Therapy
B. Med Pediatr Oncol, 1994; 23: 393-9.
Griffin TC, Morrison R, McBride D, McIntire D, Buchanan G. High-Dose
Intravenous Methylprednisolone Therapy for Severe Painful Events in Children
and Adolescents with Sickle Cell Disease. N Engl J Med. 1994; 330:733-7.
Griffin TC and Buchanan GR. Surgery in Children with Sickle Cell Disease
without Preoperative Blood Transfusion. Journal of Pediatric Surgery. 1993;
28:681-5.
Griffin TC, Tomlinson GE, Raimondi SC, Sandoval C, Timmons CF, Rosenfield
C, Carroll AJ, Schneider NR. Childhood Acute Lymphoblastic Leukemia with
Both t(1;19) and t(9;22). Leukemia, 1992; 6:535-54.
Griffin TC and Buchanan GR. Hematologic Predictors of Bone Marrow Recovery
in Neutropenic Cancer Patients Hospitalized for Fever: Implications for
Discontinuation of Antibiotics and Early Discharge From the Hospital. J
Pediatr, 1992; 121:28-33.
Griffin TC, Squires JE, Timmons CF, Buchanan GR. Chronic Human Parvovirus
B19-Induced Erythroid Hypoplasia as the Initial Manifestation of Human
Immunodeficiency Virus Infection. J Pediatr, 1991;118:899-901.
Griffin TC, Christoffel KK, Binns HJ, McGuire PA, and the Pediatric Practice
Research Group. Family History Evaluation as a Predictive Screen for Childhood
Hypercholesterolemia. Pediatrics 1989;84:365-373.
ABSTRACTS
McNall-Knapp R, Meyer W, Parkhurst-Cain J, Saxena K, Rooms L, Sexauer C,
Reeves E, Griffin T, Rowell A, Heidemann R, McKinnel J, Hanrahan J. Phase I
Evaluation of Vincristine, Irinotecan, Temozolomide, and Oral Antibiotic in Solid
Tumors. Ped Blood Cancer 47:421, 2006 (abst PB013).
Griffin T, Weitzman S, Weinstein H, Chang M, Hutchison R: A study of rituximab
and ifosfamide, carboplantin, etoposide (ICE) chemotherapy in children with
recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and mature B-cell acute
6
lymphoblastic leukemia (B-ALL). A Children’s Oncology Group Report. Ann
Oncol 19 (suppl 4): iv109, 2008 (abst 083).
McNall-Knapp R, Meyer W, Parkhurst-Cain J, Saxena K, Rooms L, Sexauer C,
Reeves E, Griffin T, Rowell A, Heidemann R, McKinnel J, Hanrahan J. Phase I
Evaluation of Vincristine, Irinotecan, Temozolomide, and Oral Antibiotic in Solid
Tumors. Ped Blood Cancer 47:421, 2006 (abst PB013).
Abla O, Sandlund JT, Blaser S, Brock P, Corbett R, Kirov I, Griffin T, Sung L,
Weitzman S. Primary Central Nervous System Lymphoma in Children: A Report
of 12 Cases. Blood 2004; 104(suppl): 901a (abst. 3300).
Cairo MS, Krailo M, Cooney E, Harrison L, Perkins LS, Fawwaz, L, Belanger R
Wiseman G, Adamson P, Griffin T, Angiolillo A. Preliminary Results of a Phase I
Study of Radioimmunotherapy with 90Y-Ibritumomab-Tiuxetan (90Y-IT) in
Children with Refractory CD20 Positive Lymphoma: The Children’s Oncology
Group Study ADVL0013. Pediatr Blood Cancer2004; 43:332 (abst. O.020).
Griffin T, Mahmoud H, Weitzman S, Schwenn M, Hutchison R, Ricketts R,
Kepner J, Murphy S. Results of a Pilot Study of Dose Intensification of
Methotrexate (MTX) and Cyclophosphamide (CP) in Patients with AdvancedStage (III/IV) Small Non-Cleaved Non-Hodgkin’s Lymphoma and B-Cell ALL (BALL): A Pediatric Oncology Group Study. Blood 2000; 96 (suppl): 135a (abst.
580).
Griffin TC, Rosen D, Bowman WP, Murphey DK. Reinstitution of Chemotherapy
Following Treatment of Epstein-Barr Virus-Associated Lymphoproliferative
Disease Complicating Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol
2000;22:377.
Hutter J, Patel P, Bertolone S, Spruce W, Griffin T.
Pediatric
Hematology/Oncology: Practice Management. Med Pediatr Oncol 1999; 33:190.
Griffin T, Bowman P, Sanders J, Friedman D, Murray J, Eames G, Shah A,
Bernini J. Favorable Results of an Intensive Protocol for Advanced-Stage T-Cell
Lymphoblastic Lymphoma and Acute Lymphoblastic Leukemia. Med Pediatr
Oncol 1999; 33:218.
Griffin TC, Bowman WP, Sanders JM, Friedman DJ, Murray JC, Eames GM,
Shah AJ, Bernini JC. Favorable Results of an Intensive Protocol for AdvancedStage Lymphoblasts Lymphoma and Acute Lymphoblastic Leukemia in
Childhood. Ann Oncol 1999; 10(Suppl 3):122.
Griffin TC, Shuster JJ, Buchanan GR, Wharam M, Murphy SB, Camitta B,
Amylon M. Slow Reduction of Peripheral Blood Blast Count is an Adverse
Prognostic Factor in Childhood T-Cell Acute Lymphoblastic Leukemia.
Proceedings ASCO 1998; 17:527a (abst 2025).
Griffin TC, Bowman WP, Sanders JA, Friedman DJ, Murray JC, Eames G,
7
Shah AJ. Treatment of Non-Hodgkin’s Lymphoma (NHL) and B-Cell Acute
Lymphoblastic Leukemia (B-ALL) in a Community Children=s Hospital - The
Cook Children's Medical Center Experience. Med. Pediatr. Oncol. 1997;
21:430.
Hutt PG, Griffin T, Fairbanks V, Hoyer J, Thibodeau S. Hemoglobin Cook,
identified by DNA sequence analysis. Blood 1995; 86 (suppl): 649a (abst. 2583).
Griffin T, Bowman P, Sanders S, Friedman D. Improved outcome for children
with Down Syndrome and acute myeloid leukemia. Submitted, ASCO, May
1995.
Sherman JM, Friedman DJ, Bowman WP, Sanders JM, Griffin TC. Restriction
fragment length polymorphism (RFLP) monitoring of engraftment in allogeneic
bone marrow transplant recipients by chemiluminescence. Blood 1994;
84(suppl): 334a (abst. 1323).
Sherman JM, Friedman DJ, Bowman WP, Sanders JM, Griffin TC. Tumor
necrosis factor - α and graft - versus - host disease in bone marrow transplant
recipients. Blood 1994; 84(suppl): 731a (abst. 2908).
Friedman D, Bowman P, Sanders J, Griffin T, Stolar K, Williams J. Successful
Treatment of High-Risk Leukemia using Continuous Infusion Etoposide (VP-16)
and Cyclophosphamide Followed by Fractionated Total Body Irradiation (TBI)
and Bone Marrow Transplantation (BMT). 1994 ASCO Annual Meeting, Dallas,
Texas.
Griffin TC, Bowman WP, Shuster J, Berard C, Cook BA, Murphy SB. High
Lymphocytic Leukemia (B-ALL) and Stage IV Diffuse, Undifferentiated
Lymphoma (DUL). Med Pediat Oncolo 1993;21:534
Griffin TC and Amylon MD. Delayed Clearance of Blasts from Peripheral Blood
Following Initiation of Therapy is Associated with an Increased Risk of Relapse in
Children with T-cell ALL: A Pediatric Oncology Group (POG) study. Proc
ASCO 1992; 11:281 (abst. 932).
Griffin TC, Morrison R, McBride D, McIntire D, and Buchanan GR. High-dose
Methylprednisolone Shortens the Duration of Painful Episodes Requiring
Hospitalization in Children with Sickle Cell Disease: Results of a Randomized,
Placebo-Controlled, Double-Blind Trial. Proceedings, 17th Annual National
Sickle Cell Disease Conference, March, 1992.
Griffin TC, Tomlinson GE, Raimondi SC, Sandoval C, Timmons CF, Rosenfield
CG, Carroll AJ, Schneider NR. Childhood Acute Lymphoblastic Leukemia with
both t(1;19) and t(9;22). Blood 1991;78:38A (abst. 144).
8
Griffin TC and Buchanan GR. Surgery in Children with Sickle Cell Disease
without Preoperative Blood Transfusion. Blood 1991;78:412A (abst. 1640).
Rogers ZR, Griffin TC. Coincident Diagnosis of Fanconi's Anemia and Acute
Lymphoblastic Leukemia. Submitted to Annual Meeting of American Society of
Pediatric Hematology/Oncology, September, 1991.
Griffin TC, Bowman WP, Sartain PA, and Buchanan GR. Treatment of Advanced
Staff Burkitt's Lymphoma in Childhood: Further Experience with Total Therapy B.
Proc. ASCO 1991;10:288 (abst. 1007)
Griffin TC, Tomlinson GR, Raimondi SC, and Schneider NR. Myelogenous
Leukemia with Abnormalities of 11q23 Following Childhood Acute Lymphoblastic
Leukemia (ALL) Presenting with both t(1;19) and t(9;22). Pediatric Res
1991;29:142A (abst. 834).
Griffin TC, Squires J, Timmons C, and Buchanan GR. Human Immunodeficiency
Virus (HIV) Infection Presenting as Chronic Parvovirus B-19-Induced Erythroid
Hypoplasia. Clinical Res 1990;38:974A.
Griffin TC, Johnson A, Dawson B, and Buchanan GR. Serum Beta- 2
Microglobulin Levels in Children and Adolescents with Hemophilia. Blood
1990;76:486A (abst. 1936).
Griffin TC and Buchanan GR. Hematologic Predictors of Bone Marrow Recovery
in Febrile, Neutropenic Cancer Patients: Implications for Early
Discharge.
Pediatric Res 1990;27:143A (abst.840).
Griffin TC, Christoffel KK, Binns HJ, McGuire PA, and the Pediatric Practice
Research Group. Family History Evaluation as a Predictive Screen for Childhood
Hypercholesterolemia. Ann NY Acad Sci, 1991;623:443-444.
Griffin TC and Buchanan GR. General Anesthesia and Surgery Without
Preoperative Blood Transfusion in Children With Sickle Cell Disease. Pediatric
Res 1989;25:151A (abst. 890).
Griffin TC, Christoffel KK, Binns HJ, McGuire PA, and the Pediatric Practice
Research Group.
Family History as a Screen for Childhood
Hypercholesterolemia. Pediatric Res 1988;23:291A (abst. 543).
Griffin TC, Christoffel KK, Binns HJ, McGuire PA, and the Pediatric Practice
Research Group.
Is Family History a Good Screen for Childhood
Hypercholesterolemia? Clinical Res 1987;35:914A.
Griffin TC, McNall-Knapp R, Meyer W, Cain JP, Saxena K, Rooms L, Sexauer C,
9
Reeves E, Rowell A, Heideman R, McKinnell J, Hanrahan J. Phase I Evaluation
of Vincristine, Irinotecan, Temozolomide, and Oral Antibiotic in Solid
Tumors.SIOP (abst.1057).
PRESENTATIONS
A study of rituximab and ifosfamide, carboplantin, etoposide (ICE) chemotherapy
in children with recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and
mature B-cell acute lymphoblastic leukemia (B-ALL). A Children’s Oncology
Group Report. Platform presentation, 10th International Conference on Malignant
Lymphoma, June 5, 2008.
A study of rituximab and ifosfamide, carboplantin, etoposide (ICE) chemotherapy
in children with recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and
mature
B-cell acute lymphoblastic leukemia (B-ALL). A Children’s Oncology Group
Report. Platform presentation, Annual Meeting, American Society of Pediatric
Hematology/Oncology, May 16, 2008.
Results of a Pilot Study of Dose Intensification of Methotrexate (MTX) and
Cyclophosphamide (CP) in Patients with Advanced-Stage (III/IV) Small NonCleaved Non-Hodgkin’s Lymphoma and B-Cell ALL (B-ALL): A Pediatric
Oncology Group Study. Poster Presentation, Annual Meeting, American Society
of Hematology, December 2, 2000.
Reinstitution of Chemotherapy Following Treatment of Epstein-Barr VirusAssociated Lymphoproliferative Disease Complicating Acute Lymphoblastic
Leukemia. Poster Presentation, 18th Annual Meeting, American Society of
Pediatric Hematology/Oncology, September 14, 2000.
Hematology/Oncology Practice in a Pediatric Integrated Delivery System.
Platform Presentation, Annual Meeting, American Society of Pediatric
Hematology/Oncology, Montreal, Canada, September 18, 1999.
Favorable Results of an Intensive Protocol for Advanced-Stage T-Cell
Lymphoblastic Lymphoma and Acute Lymphoblastic Leukemia in Childhood
Poster Presentation, 31st Annual Meeting, International Society of Pediatric
Oncology, Montreal, Canada, September 14, 1999.
Experience with Use of a Clinical Pathway for Management of Painful Episodes
Complicating Sickle Cell Disease and Impact on Hospital Resource Utilization.
Poster Presentation, Annual Meeting, National Sickle Cell Disease Conference,
March 7, 1999.
Slow Reduction of Peripheral Blood Blast Count is an Adverse Prognostic
10
Factor in Childhood T-Cell Acute Lymphoblastic Leukemia. Platform
Presentation, Annual Meeting, American Society of Clinical Oncology, May 18,
1998.
Treatment of Non-Hodgkin’s Lymphoma (NHL) and B-Cell Acute
Lymphoblastic Leukemia (B-ALL) in a Community Children=s Hospital The Cook Children=s Medical Center Experience. Poster Presentation,
29th Annual Meeting of International Society of Pediatric Oncology, Istanbul,
Turkey, September 26, 1997.
High Prevalence of Orofacial Symptoms in Non-African Children with B-Cell
Acute Lymphocytic Leukemia and Stage IV Diffuse, Undifferentiated Lymphoma
Platform Presentation, 25th Annual Meeting of the International Society of
Pediatric Oncology, San Francisco, CA, October 7, 1993.
"Medical Advances" presented at the 7th Annual Parent Teaching Conference,
"Childhood Cancer: Challenges, Choices and Change" held in Austin, Texas on
July 18-19, 1992.
High-dose Methylprednisolone Shortens the Duration of Painful Episodes
Requiring Hospitalization in Children with Sickle Cell Disease: Results of a
Randomized,Placebo-Controlled, Double-Blind Trial. Platform Presentation, 17th
Annual National Sickle Disease Conference, March 16, 1992.
Childhood Acute Lymphoblastic Leukemia with Both t(1;19) and t(9;22). Poster
Presentation, Annual Meeting, American Society of Hematology, December 7,
1991.
Griffin TC, Bowman WP, Sartain PA, Buchanan GR. Treatment of Advanced
Stage Burkitt's Lymphoma in Childhood: Further Experience with Total
Therapy B. Poster Presentation, Annual Meeting, Texas Pediatric Society,
September 28, 1991.
Treatment of Advanced Stage Burkitt's Lymphoma in Childhood: Further
Experience with Total Therapy B. Poster Presentation, Annual Meeting,
American Society of Clinical Oncology, April 21, 1991.
Human Immunodeficiency Virus (HIV) Infection Presenting as Chronic Parvovirus
B19-Induced Erythroid Hypoplasia. Platform Presentation, Annual Meeting,
Southern Society of Pediatric Research, February, 1991
Hematologic Predictors of Bone Marrow Recovery in Febrile, Neutropenic
Cancer Patients: Implications for Early Discharge. Platform Presentation, Annual
Meeting, Society for Pediatric Research, May, 1990.
11
Family History Evaluation as a Predictive Screen for Childhood
Hypercholesterolemia. Poster Presentation, New York Academy Sciences on
Hyperlipidemia in Childhood, May, 1990.
Identification of Hypercholesterolemic Children-Does Family History Help?
Annual Meeting, American Academy of Pediatrics, Section on Clinical
Epidemiology, October, 1989.
General Anesthesia and Surgery Without Preoperative Blood Transfusion in
Children with Sickle Cell Disease. Platform Presentation, Annual Meeting,
Society for Pediatric Research, May, 1989.
Family History as a Screen for Childhood Hypercholesterolemia. Platform
Presentation, Annual Meeting, Society for Pediatric Research, May, 1988.
Is Family History a Good Screen for Childhood Hypercholesterolemia? Platform
Presentation, Plenary Session, Midwest Society for Pediatric Research,
November, 1987.
PERSONAL
Birthdate: 9/27/58
Married: Marianne Dykema Griffin
Children: Matthew (1987), Alexander (1989) and William (1995)
REFERENCES:
Upon Request
12